MIBG Combination Therapies Show Promise in Neuroblastoma
July 20, 2023
Study shows that combining MIBG therapy with immunotherapy and vorinostat may boost response rates in patients with relapsed neuroblastoma.
More than 80 Southern California businesses will rally the community during March in support of pediatric care and research at CHLA.
Sign up to receive our monthly newsletter, latest news, events and stories delivered right to your inbox.